Bayesian Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-74,175
| Closed | -$643K | – | 962 |
|
|
2024
Q1 | $643K | Buy |
+74,175
| New | +$643K | 0.06% | 384 |
|
|
2022
Q3 | – | Sell |
-17,000
| Closed | -$483K | – | 910 |
|
|
2022
Q2 | $483K | Sell |
17,000
-15,645
| -48% | -$445K | 0.09% | 343 |
|
|
2022
Q1 | $1.15M | Buy |
32,645
+27,400
| +522% | +$966K | 0.17% | 177 |
|
|
2021
Q4 | $220K | Buy |
5,245
+949
| +22% | +$39.8K | 0.07% | 304 |
|
|
2021
Q3 | $211K | Buy |
+4,296
| New | +$211K | 0.06% | 336 |
|